This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2006 Remove Consumption Remove DEA Remove Topical
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

31) The United States DEA has stated that small amounts of other cannabinoids will also occur in all cannabis extracts, even those that purport to be CBD only – unless synthesized de novo, CBD isolate will always contain small amounts of THC when extracted from a plant. Cell Calcium 39 (2006) 155–162. 32: United States DEA.

Extraction 73
Extraction Pharmaceutical CBD Epilepsy 73
article thumbnail

Meadowlands: Update from Local Regulators with the Cannabis Czars of Los Angeles, San Francisco…

Meadow

JULY 13, 2018

The panel covered a wide range of topics local regulators are currently dealing with, including reconciling local and state regulations, enforcement of illicit businesses, license caps, equity and diversity, delivery, onsite consumption, and, of course, taxes. 43:20) What is going on in your respective cities with onsite consumption ?

Wellness and Beauty 40
Wellness and Beauty Consumption Policy Cannabis 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024